DB

Deep Bhanushanker Kalola

Active Director Designated Partner DIN 08959620
DIN 08959620 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Deep Bhanushanker Kalola

Data last updated:

Deep Bhanushanker Kalola is a Designated Partner at Seven Oaks Lifesciences Llp (since 2020). The company operates in Pharma.

DIN 08959620
Primary Designation Designated Partner
Industry Pharma
First Appointment 12 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Nov 20202020Active

Board colleagues of Deep Bhanushanker Kalola

NameDINCompanyDesignation
Puspaben Fulashankerbhai Trivedi08922656Seven Oaks Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Seven Oaks Lifesciences Llp
Premium access

Shareholding and investment profile for Deep Bhanushanker Kalola

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deep Bhanushanker Kalola

Deep Bhanushanker Kalola currently holds 1 directorship: Seven Oaks Lifesciences Llp (Designated Partner, since 12 Nov 2020).

Deep Bhanushanker Kalola was first appointed on 12 Nov 2020 as Designated Partner at Seven Oaks Lifesciences Llp.

The current boards of Deep Bhanushanker Kalola's companies include Puspaben Fulashankerbhai Trivedi (Seven Oaks Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available